Bayland Capital
Beijingpharmaron.com
Overview
Bayland Capital is a corporate venture capital arm of Pharmaron that invests in companies developing medicines, medical devices, and other medical technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PAQ | Jan 2026 | Series B Extension | Co-investor |
| Vibrant Therapeutics | Jan 2026 | Early Funding | Co-investor |
| CN Bio | Apr 2024 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.